Why certain anticancer cancer drugs cause heart failure
January 12th, 2010 - 5:09 pm ICT by ANIWashington, Jan 12 (ANI): Scientists at the University of Texas MD Anderson Cancer Center, Houston, say they have discovered why certain anticancer drugs cause heart failure in some patients.
Several types of cancer are characterized by overexpression of PDGFR proteins, and molecules that inhibit PDGFR signaling have proven useful anticancer therapeutics.
However, recently, several such anticancer drugs have been associated with clinical heart failure in some patients.
Aarif Khakoo and colleagues have now identified a role for PDGFR-beta in mouse heart muscle cells that might help explain why inhibitors of PDGFR signaling can cause heart failure.
In the study, expression and activation of PDGFR-beta was found to increase dramatically in the hearts of mice exposed to pressure overload (a model of high blood pressure).
Further, mice lacking PDGFR-beta in heart muscle cells developed more severe heart failure when exposed to pressure overload than did normal mice.
Further analysis indicated that PDGFR-beta in heart muscle cells contributes to the protective response to pressure overload by triggering the growth of new blood vessels, providing new insight into the physiologic functions of PDGFR-beta. (ANI)
- Growth factor targeted by cancer drugs also prevents heart problem - Jan 12, 2010
- Blocking action of protein blunts serious ill effects of high BP on heart - May 03, 2011
- Cancer drug can reverse heart failure - May 31, 2011
- How genetic changes make some brain cancers more aggressive - Oct 02, 2010
- Viagra relatives could minimize abnormally large hearts - Sep 25, 2009
- Molecular 'playbook' to stop heart failure risk factor found - Sep 24, 2010
- Rest can undo damage to heart cells - Apr 02, 2012
- Scientists discover potential new drug therapy for kidney diseases - Apr 27, 2011
- Pain killers retard recovery from heart attack - Apr 09, 2012
- Tweaking DNA can counteract heart injury - Dec 24, 2010
- New proteins that regulate blood pressure, flow identified - Jul 08, 2010
- New potential target for breast cancer therapy identified - Dec 23, 2010
- DNA damage can help protect the body from infection - Apr 01, 2011
- Potential treatment target for congenital heart disease identified - Feb 22, 2011
- New approach could reverse liver failure - Aug 06, 2012
Tags: anderson cancer center, anticancer drugs, blood vessels, cancer drugs, cause heart failure, heart failure, heart muscle cells, high blood pressure, md anderson cancer, md anderson cancer center, md anderson cancer center houston, mice, new blood, overexpression, physiologic functions, protective response, texas md anderson, texas md anderson cancer center, types of cancer, university of texas md anderson cancer center